调节瘤细胞以唤醒T细胞抗瘤功能并增强黑色素瘤免疫疗法
Weihan Zhang1, Shijun Yuan1, Zipeng Zhang2
1Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Biomaterials
|December 22, 2024
概括
这项研究开发了对pH反应的纳米粒子 (NL/PLDs),以抵消瘤诱导的T细胞功能障碍. 这些纳米粒子增强抗瘤免疫力,并显示出改善癌症免疫疗法的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 生物化学 生物化学
背景情况:
- 瘤细胞创造了一个免疫抑制的微环境 (TIME),损害T细胞功能,导致免疫逃脱和癌症进展.
- 对抗瘤诱导的T细胞功能障碍对于有效的癌症免疫疗法至关重要.
研究的目的:
- 开发新的pH响应性脂质纳米颗粒 (NL/PLDs) 与PCSK9小RNA,隆尼达胺 (LND) 和低剂量多克索鲁比 (DOX) 携带.
- 评估NL/PLD恢复T细胞功能和增强抗瘤免疫力的能力.
主要方法:
- 准备pH响应的脂质纳米颗粒 (NL/PLDs),同时提供PCSK9的shRNA,LND和DOX.
- 在黑色素瘤小鼠模型中评估NL/PLD对瘤免疫性,MHC-I表达和乳酸抑制的影响.
- 在体内对NL/PLD和抗PD-1 (aPD-1) 的联合治疗进行评估.
主要成果:
- 通过促进T细胞激活,识别和杀死,NL/PLDs有效地逆转T细胞功能障碍.
- 用NL/PLDs治疗显著降低了免疫抑制瘤微环境 (TIME),并增强了CD8+ T细胞介导的抗瘤免疫力.
- 结合NL/PLDs与aPD-1的联合疗法表现出强大的抗瘤作用和改善的免疫治疗疗效.
结论:
- NL/PLDs是克服瘤诱导的T细胞抑制和增强抗瘤免疫力的有希望的策略.
- 这种方法为调节瘤免疫抑制信号提供了新的见解,以改善临床癌症治疗.
- 开发的纳米颗粒显示出提高当前免疫疗法的疗效的巨大潜力.
相关概念视频
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:27Cytotoxic T Cells-mediated Immune Response
844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K